Moleculin Biotech
(NASDAQ) MBRX
Moleculin Biotech Financials at a Glance
Market Cap
$15.64M
Revenue (TTM)
$0.00
Net Income (TTM)
-$30.33M
EPS (TTM)
-$28.04
P/E Ratio
-0.10
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Price
$2.93
Volume
28,724
Open
$2.61
Price
$2.93
Volume
28,724
Open
$2.61
Previous Close
$2.93
Daily Range
$2.61 - $2.94
52-Week Range
$1.79 - $24.00
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Price
$2.93
Volume
28,724
Open
$2.61
Previous Close
$2.93
Daily Range
$2.61 - $2.94
52-Week Range
$1.79 - $24.00
Estimated Earnings Date
Aug 11, 2026
MBRX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Moleculin Biotech
Industry
Biotechnology
Sector
Health CareEmployees
17
CEO
Walter V. Klemp, CPA
Website
www.moleculin.comHeadquarters
Houston, TX 77007, US
MBRX Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
3114.17%
Return on Capital
-163.38%
Return on Assets
-129.83%
Earnings Yield
-10.00%
Dividend Yield
0.00%
Payout Ratio
-5.82%
Stock Overview
Market Cap
$15.64M
Shares Outstanding
5.34M
Volume
28.72K
Avg. Volume
382.12K
Financials (TTM)
Gross Profit
-$37.00K
Operating Income
-$27.03M
EBITDA
-$30.26M
Operating Cash Flow
-$24.28M
Capital Expenditure
$0.00
Free Cash Flow
-$24.28M
Cash & ST Invst.
$10.32M
Total Debt
$326.00K
Moleculin Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$8.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$15.64M
N/A
Market Cap/Employee
$919.74K
N/A
Employees
17
N/A
Net Income
-$12.85M
-99.6%
EBITDA
-$12.84M
-100.4%
Quarterly Fundamentals
Total Cash
$10.32M
+33.7%
Total Debt
$326.00K
-27.6%
Accounts Receivable
$9.00K
+50.0%
Inventory
$0.00
N/A
Long Term Debt
$185.00K
-43.3%
Short Term Debt
$141.00K
+13.7%
Return on Assets
-1.30%
N/A
Return on Invested Capital
-1.76%
N/A
Free Cash Flow
-$6.11M
-33.9%
Operating Cash Flow
-$6.11M
-33.9%